Point-of-care lung ultrasound, lung CT and NEWS to predict adverse outcomes and mortality in COVID-19 associated pneumonia

O Bardakci, M Daş, G Akdur, C Akman… - Journal of Intensive …, 2022 - journals.sagepub.com
Introduction: The appraisal of disease severity and prediction of adverse outcomes using
risk stratification tools at early disease stages is crucial to diminish mortality from coronavirus …

Exploring m6A‐RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome

R Faraj, Y Liang, A Feng, J Wu, SM Black… - Pulmonary …, 2023 - Wiley Online Library
Abstract N6‐methyladenosine (m6A) is the most common methylation modification in
mammalian messenger RNA (mRNA) and noncoding RNAs. m6A modification plays a role …

[HTML][HTML] Practice of 18F-FDG-PET/CT in ICU patients: a systematic review

B van Leer, ND van Rijsewijk, MWN Nijsten… - Seminars in Nuclear …, 2023 - Elsevier
18 F-FDG-PET/CT imaging has become a key tool to evaluate infectious and inflammatory
diseases. However, application of 18 F-FDG-PET/CT in patients in the intensive care unit …

[HTML][HTML] Activating transcription factor 6 in the endothelial context

N Barabutis - Pulmonary Pharmacology & Therapeutics, 2023 - ncbi.nlm.nih.gov
Acute Respiratory Distress Syndrome (ARDS) is the cause of thousands of deaths in the
intensive care units, since efficient therapies for that disorder do not exist. Herein, and based …

[HTML][HTML] Respiratory failure

VS Mirabile, E Shebl, A Sankari, B Burns - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Respiratory Failure - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …

[HTML][HTML] Identifying vital sign trajectories to predict 28-day mortality of critically ill elderly patients with acute respiratory distress syndrome

M Li, F Liu, Y Yang, J Lao, C Yin, Y Wu, Z Yuan… - Respiratory …, 2024 - Springer
Background The mortality rate of acute respiratory distress syndrome (ARDS) increases with
age (≥ 65 years old) in critically ill patients, and it is necessary to prevent mortality in elderly …

[HTML][HTML] An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium

JS Lazo, RML Colunga-Biancatelli, PA Solopov… - Slas Discovery, 2023 - Elsevier
The genesis of most older medicinal agents has generally been empirical. During the past
one and a half centuries, at least in the Western countries, discovering and developing …

[HTML][HTML] Pneumonia and Related Conditions in Critically Ill Patients—Insights from Basic and Experimental Studies

DA Kashatnikova, MB Khadzhieva… - International Journal of …, 2022 - mdpi.com
Pneumonia is an acute infectious disease with high morbidity and mortality rates.
Pneumonia's development, severity and outcome depend on age, comorbidities and the …

Differential changes in expression of inflammatory mRNA and protein after oleic acid-induced acute lung injury

R Golding, RK Braun, L Miller, M Lasarev… - Experimental Lung …, 2024 - Taylor & Francis
Abstract Background: Acute Respiratory Distress syndrome (ARDS) is a clinical syndrome of
noncardiac pulmonary edema and inflammation leading to acute respiratory failure. We …

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

G Poulakou, M Barakat, RJ Israel… - Clinical and …, 2023 - Wiley Online Library
There is an unmet medical need for effective treatments for hospitalized patients with
coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with …